News

Amunix Pharmaceuticals Inc, a biopharmaceutical company focused on treating patients with solid tumor cancers, has raised $117 million in Series B financing.

GSV Ventures, a woman-owned venture firm focused on education technology, has closed its second fund at $180 million.

BlossomHill Therapeutics Inc, a biopharmaceutical company focusing on oncology and autoimmune disorders, has raised $71 million in Series A financing.

Postscript, a text message marketing platform for Shopify stores, has secured $35 million in Series B funding.

Bionaut Labs, a developer of treatments for central nervous system disorders, has secured $20 million in financing.

Companion, a developer of dog training products, has secured $8 million in seed funding.

Raven Indigenous Capital Partners, a Canadian Indigenous venture capital firm, has closed its debut impact fund, raising C$25 million.

Hopin, a virtual events provider, has raised $400 million in Series C funding.

Jungle Scout, a platform for selling on Amazon, has raised $110 million in funding.

Clari, a revenue operations company, has secured $150 million in Series E funding.